274 related articles for article (PubMed ID: 22129322)
21. Albumin Substitution in Decompensated Liver Cirrhosis: Don't Forget Zinc.
Grüngreiff K; Gottstein T; Reinhold D; Blindauer CA
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836265
[TBL] [Abstract][Full Text] [Related]
22. Treatment of ascites and renal failure in cirrhosis.
Ginès P; Arroyo V; Rodés J
Baillieres Clin Gastroenterol; 1989 Jan; 3(1):165-86. PubMed ID: 2655748
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
[TBL] [Abstract][Full Text] [Related]
24. Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites.
Di Pascoli M; Fasolato S; Piano S; Bolognesi M; Angeli P
Liver Int; 2019 Jan; 39(1):98-105. PubMed ID: 30230204
[TBL] [Abstract][Full Text] [Related]
25. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.
Nazar A; Guevara M; Sitges M; Terra C; Solà E; Guigou C; Arroyo V; Ginès P
J Hepatol; 2013 Jan; 58(1):51-7. PubMed ID: 22989573
[TBL] [Abstract][Full Text] [Related]
26. [Ascites, hepatorenal syndrome and spontaneous bacterial peritonitis in patients with portal hypertension].
Kim YS
Korean J Gastroenterol; 2010 Sep; 56(3):168-85. PubMed ID: 20847607
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of cirrhotic complications with human serum albumin].
Henriksen JH; Ring-Larsen H
Ugeskr Laeger; 2005 Jan; 167(4):414. PubMed ID: 15719571
[No Abstract] [Full Text] [Related]
28. Current indications for the use of albumin in the treatment of cirrhosis.
Alves de Mattos A
Ann Hepatol; 2011 May; 10 Suppl 1():S15-20. PubMed ID: 21566250
[TBL] [Abstract][Full Text] [Related]
29. [Natural course and physiopathology of ascites in the cirrhotic patient].
Bernardi M; Colantoni A; Caraceni P; Sica G; Trevisani F
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():30S-38S. PubMed ID: 9004818
[TBL] [Abstract][Full Text] [Related]
30. Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials.
Bai Z; Wang L; Wang R; Zou M; Méndez-Sánchez N; Romeiro FG; Cheng G; Qi X
Hepatol Int; 2022 Dec; 16(6):1468-1483. PubMed ID: 36048318
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide and renal function in cirrhotic patients with ascites: from physiopathology to practice.
Grangé JD; Amiot X
Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):567-70. PubMed ID: 15167158
[TBL] [Abstract][Full Text] [Related]
32. Review article: albumin in the treatment of liver diseases--new features of a classical treatment.
Arroyo V
Aliment Pharmacol Ther; 2002 Dec; 16 Suppl 5():1-5. PubMed ID: 12423447
[TBL] [Abstract][Full Text] [Related]
33. Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study.
Fassio E; Terg R; Landeira G; Abecasis R; Salemne M; Podesta A; Rodriguez P; Levi D; Kravetz D
J Hepatol; 1992 Mar; 14(2-3):310-6. PubMed ID: 1380024
[TBL] [Abstract][Full Text] [Related]
34. Review: the controversy over the pathophysiology of ascites formation in cirrhosis.
Wong F; Girgrah N; Blendis L
J Gastroenterol Hepatol; 1997 Jun; 12(6):437-44. PubMed ID: 9195401
[TBL] [Abstract][Full Text] [Related]
35. Update on peripheral arterial vasodilation, ascites and hepatorenal syndrome in cirrhosis.
Knotek M; Rogachev B; Schrier RW
Can J Gastroenterol; 2000 Nov; 14 Suppl D():112D-121D. PubMed ID: 11110623
[TBL] [Abstract][Full Text] [Related]
36. Role of human albumin in the management of complications of liver cirrhosis.
Bernardi M; Ricci CS; Zaccherini G
J Clin Exp Hepatol; 2014 Dec; 4(4):302-11. PubMed ID: 25755577
[TBL] [Abstract][Full Text] [Related]
37. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.
Karwa R; Woodis CB
Ann Pharmacother; 2009 Apr; 43(4):692-9. PubMed ID: 19299324
[TBL] [Abstract][Full Text] [Related]
38. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.
Sola-Vera J; Miñana J; Ricart E; Planella M; González B; Torras X; Rodríguez J; Such J; Pascual S; Soriano G; Pérez-Mateo M; Guarner C
Hepatology; 2003 May; 37(5):1147-53. PubMed ID: 12717396
[TBL] [Abstract][Full Text] [Related]
39. [Albumin substitution : A review of the indications in general internal medicine].
Dumas D; Benmachiche M; Gachoud D
Rev Med Suisse; 2021 Nov; 17(760):2022-2026. PubMed ID: 34817939
[TBL] [Abstract][Full Text] [Related]
40. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
